Insider Transactions in Q1 2021 at Ligand Pharmaceuticals Inc (LGND)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2021
|
John W Kozarich Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.76%
|
$25,000
$10.12 P/Share
|
|
Feb 15
2021
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,309
-1.88%
|
$397,148
$172.46 P/Share
|
|
Feb 15
2021
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,212
-0.51%
|
$896,464
$172.46 P/Share
|
|
Feb 15
2021
|
Matthew W Foehr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,098
-0.62%
|
$532,856
$172.46 P/Share
|
|
Feb 15
2021
|
Charles S Berkman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,015
-1.18%
|
$174,580
$172.46 P/Share
|
|
Feb 11
2021
|
Todd C Davis Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,474
+4.7%
|
$482,430
$195.91 P/Share
|
|
Feb 10
2021
|
Todd C Davis Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,083
-9.63%
|
$1,082,679
$213.14 P/Share
|
|
Feb 09
2021
|
Stephen L Sabba Director |
SELL
Open market or private sale
|
Direct |
14,670
-19.02%
|
$3,051,360
$208.28 P/Share
|
|
Feb 09
2021
|
Stephen L Sabba Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,670
+17.28%
|
$161,370
$11.33 P/Share
|
|
Feb 05
2021
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,970
-0.86%
|
$602,910
$203.03 P/Share
|
|
Feb 05
2021
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
114,666
+14.3%
|
$1,375,992
$12.26 P/Share
|
|
Feb 05
2021
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
54,666
-16.05%
|
$11,097,198
$203.4 P/Share
|
|
Feb 04
2021
|
Matthew W Foehr |
SELL
Open market or private sale
|
Direct |
44,547
-20.94%
|
$7,840,272
$176.86 P/Share
|
|
Feb 04
2021
|
Matthew W Foehr |
BUY
Exercise of conversion of derivative security
|
Direct |
45,547
+8.95%
|
$2,186,256
$48.17 P/Share
|
|
Feb 04
2021
|
Charles S Berkman |
SELL
Open market or private sale
|
Direct |
18,097
-38.5%
|
$3,221,266
$178.5 P/Share
|
|
Feb 03
2021
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,819
+20.58%
|
-
|
|
Feb 03
2021
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,608
+4.22%
|
-
|
|
Feb 03
2021
|
Matthew W Foehr |
BUY
Grant, award, or other acquisition
|
Direct |
6,595
+3.79%
|
-
|
|
Feb 03
2021
|
Charles S Berkman |
BUY
Grant, award, or other acquisition
|
Direct |
3,491
+6.91%
|
-
|
|
Jan 27
2021
|
Todd C Davis Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,456
+4.45%
|
$277,528
$113.5 P/Share
|
|
Jan 27
2021
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+11.13%
|
$1,260,000
$18.2 P/Share
|
|
Jan 27
2021
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
40,000
-14.11%
|
$7,280,000
$182.0 P/Share
|
|
Jan 25
2021
|
Charles S Berkman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-1.54%
|
$208,884
$156.06 P/Share
|
|
Jan 25
2021
|
Charles S Berkman |
BUY
Grant, award, or other acquisition
|
Direct |
3,736
+4.09%
|
-
|
|
Jan 25
2021
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,111
-3.41%
|
$329,316
$156.01 P/Share
|
|
Jan 25
2021
|
Matthew E Korenberg President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,108
+10.23%
|
-
|
|
Jan 25
2021
|
Matthew W Foehr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,325
-1.03%
|
$518,700
$156.01 P/Share
|
|
Jan 25
2021
|
Matthew W Foehr |
BUY
Grant, award, or other acquisition
|
Direct |
8,515
+2.57%
|
-
|
|
Jan 25
2021
|
John L Higgins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,441
-1.52%
|
$1,160,796
$156.01 P/Share
|
|
Jan 25
2021
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,553
+3.07%
|
-
|
|
Jan 25
2021
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
50,000
-17.52%
|
$7,950,000
$159.0 P/Share
|
|
Jan 25
2021
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+14.91%
|
$700,000
$14.47 P/Share
|